Skip to main content

Contraindications of Digoxin


Contraindications of Digoxin

Absolute Contraindications :

❶ Ventricular fibrillation

❷ Digoxin hypersensitivity


Relative Contraindications :

① Acute MI

② Myocarditis

③ HOCM

④ Sick sinus syndrome

⑤ AV block (2nd- or 3rd-degree) without a pacemaker

⑥ WPW syndrome with AF


Drug Interactions that Can Function as Contraindications :

☒ Amiodarone

☒ Dronedarone

☒ Verapamil

☒ Macrolides (e.g., clarithromycin)

☒ Itraconazole


Conditions that Increase Risk of Digoxin Toxicity :

➠ Renal impairment

➠ Hyperthyroidism or Hypothyroidism

➠ Elderly or low body mass

➠ Electrolyte disturbances :

 ➜ Hypokalemia

 ➜ Hypomagnesemia

 ➜ Hypercalcemia


For more infographics keep visiting: drmusmanjaved.com


Contraindications of Digoxin – A Detailed Clinical Guide

Digoxin is one of the oldest and most widely used cardiac medications, particularly in patients with atrial fibrillation and heart failure with reduced ejection fraction (HFrEF) whose primary problem is symptomatic congestion despite optimal therapy.

Although effective, digoxin has a narrow therapeutic index, meaning the margin between therapeutic and toxic levels is small. Therefore, understanding its contraindications, drug interactions, and toxicity-predisposing conditions is crucial for safe use.


This article reviews all contraindications—absolute, relative, and interaction-based—along with clinical reasoning behind each.



---


πŸ”΄ Absolute Contraindications


These are conditions in which digoxin must not be used under any circumstance.


1. Ventricular Fibrillation


Digoxin is completely ineffective in controlling ventricular fibrillation and may worsen arrhythmogenicity due to increased intracellular calcium.

It should never be given in a patient with ongoing VF.


2. Digoxin Hypersensitivity


Any history of allergic reaction—urticaria, angioedema, rash, or anaphylaxis—makes further exposure unsafe.



---


🟠 Relative Contraindications


These are situations where digoxin may be used but require caution and often specialist input.


1. Acute Myocardial Infarction (AMI)


Digoxin increases myocardial oxygen consumption and can worsen ischemia or provoke arrhythmias during an acute infarction.


2. Myocarditis


Inflamed myocardium is more irritable, and digoxin can heighten arrhythmia risk due to increased automaticity.


3. Hypertrophic Obstructive Cardiomyopathy (HOCM)


Digoxin increases contractility.

In HOCM, this can worsen LVOT obstruction and exacerbate symptoms.


4. Sick Sinus Syndrome


Digoxin increases vagal tone and may worsen underlying bradyarrhythmias unless a pacemaker is present.


5. 2nd- or 3rd-Degree AV Block (Without Pacemaker)


Because digoxin slows AV nodal conduction, it can precipitate complete heart block in patients with pre-existing conduction disease.


6. WPW Syndrome with Atrial Fibrillation


This is a classic danger:

Digoxin enhances conduction through accessory pathways, leading to very rapid ventricular rates or degeneration into VF.



---


πŸ”΄ Drug Interactions That Act as Contraindications


Certain medications dramatically increase serum digoxin levels or enhance toxicity. Their presence often makes digoxin unsafe unless dose adjustment and close monitoring occur.


1. Amiodarone


Inhibits P-glycoprotein, causing digoxin levels to double.

Co-administration requires a 50% dose reduction and serum level monitoring.


2. Dronedarone


Similar interaction to amiodarone—strong P-gp inhibition and increased risk of bradyarrhythmias.


3. Verapamil


Raises digoxin concentrations and adds a compounding negative chronotropic effect.


4. Macrolides (e.g., clarithromycin)


Suppress gut flora responsible for digoxin metabolism, causing dangerous toxicity surges.


5. Itraconazole


Potent P-gp inhibitor → markedly elevated digoxin levels.


Clinical pearl:

Any new P-glycoprotein inhibitor in a patient on digoxin requires immediate reassessment of therapy.



---


🟑 Conditions That Increase the Risk of Digoxin Toxicity


These are not absolute contraindications, but they increase susceptibility dramatically.


1. Renal Impairment


Digoxin is primarily renally cleared. Even mild renal dysfunction can raise serum levels and lead to toxicity (nausea, vision changes, arrhythmias).


2. Thyroid Disease


Hyperthyroidism: Increased metabolism → fluctuating digoxin effects and arrhythmia risk.


Hypothyroidism: Reduced clearance → higher digoxin levels.



3. Elderly Age or Low Body Mass


Reduced volume of distribution and decreased renal clearance make older adults highly prone to toxicity.


4. Electrolyte Abnormalities


These are the most dangerous enhancers of toxicity:


Hypokalemia: Low K⁺ increases digoxin binding to the Na⁺/K⁺ pump → potentiates toxicity.


Hypomagnesemia: Promotes ventricular arrhythmias.


Hypercalcemia: Amplifies calcium-overload effects → triggered arrhythmias.



Remember:

“Low K, Low Mg, High Ca = Perfect Storm for Digoxin Toxicity.”



---


Clinical Practice Takeaways


Always check renal function and electrolytes before prescribing.


Avoid digoxin in patients with WPW-AF, advanced AV block, or myocarditis.


Review all medications for P-gp interactions.


In elderly patients, start with very low doses and monitor levels.


Digoxin toxicity can be life-threatening—recognize early symptoms (GI upset, yellow vision, bradyarrhythmias, VT/VF risk).


---

Conclusion


Digoxin remains a valuable medication when used correctly. However, its narrow therapeutic window requires careful assessment of contraindications and interacting factors. Understanding these risk modifiers helps clinicians use digoxin safely and effectively, avoiding preventable complications.

Comments

Popular posts from this blog

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB)

Brugada ECG vs Incomplete Right Bundle Branch Block (iRBBB) Why this differentiation matters Brugada pattern is a malignant channelopathy associated with sudden cardiac death, while incomplete RBBB is usually a benign conduction variant. Mislabeling Brugada as iRBBB can be fatal; overcalling iRBBB as Brugada can lead to unnecessary anxiety and ICD implantation. --- 1. Basic Definitions Brugada ECG Pattern Primary repolarization abnormality Genetic sodium-channel disorder Characteristic ST-segment elevation in V1–V3 Risk of ventricular fibrillation and sudden death Incomplete RBBB (iRBBB) Depolarization abnormality Delay in right ventricular conduction Common in healthy individuals Usually asymptomatic and benign --- 2. ECG Morphology: Side-by-Side Comparison QRS Duration Brugada: QRS usually <120 ms iRBBB: QRS <120 ms, but with RBBB morphology --- V1–V2 Pattern (Key Differentiator) Brugada Pseudo-RBBB appearance ST elevation ≥2 mm ST segment is coved or saddleback Terminal QRS bl...

π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š

 π˜Όπ™£π™©π™žπ™˜π™€π™–π™œπ™ͺπ™‘π™–π™©π™žπ™€π™£ π˜Όπ™›π™©π™šπ™§ π™Žπ™©π™§π™€π™ π™š in  Patient with AF and acute IS/TIA European Heart Association Guideline recommends: • 1 days after TIA • 3 days after mild stroke • 6 days after moderate stroke • 12 days after severe stroke Early anticoagulation can decrease a risk of recurrent stroke and embolic events but may increase a risk of secondary hemorrhagic transformation of brain infarcts.  The 1-3-6-12-day rule is a known consensus with graded increase in delay of anticoagulation between 1 and 12 days after onset of ischemic stroke or transient ischemic attack(TIA), according to neurological severity based on European expert opinions. However, this rule might be somewhat later than currently used in a real-world practical setting.

Acute Treatment of Hyperkalemia

Acute Treatment of Hyperkalemia – A Practical, Bedside-Oriented Guide Hyperkalemia is a potentially life-threatening electrolyte abnormality that demands prompt recognition and decisive management. The danger lies not only in the absolute potassium value but in its effects on cardiac conduction, which can rapidly progress to fatal arrhythmias. Acute treatment focuses on three parallel goals: stabilizing the cardiac membrane, shifting potassium into cells, and removing excess potassium from the body. Understanding this stepwise approach helps clinicians act quickly and rationally in emergency settings. Why Hyperkalemia Is Dangerous Potassium plays a key role in maintaining the resting membrane potential of cardiac myocytes. Elevated serum potassium reduces the transmembrane gradient, leading to slowed conduction, ECG changes, ventricular arrhythmias, and asystole. Importantly, ECG changes do not always correlate with potassium levels, so treatment decisions should be based on clinical c...